Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription Articles published in Pediatr Infect Dis J Retrieve available abstracts of 64 articles: HTML format

Single Articles

June 2026
1. KINKADE CW, Sheng Q, Peter O, Kumar A, et al
   Epigenetic Age Acceleration, Neurocognition and Oral Health in Nigerian Adolescents With and Without HIV.
   Pediatr Infect Dis J. 2026 Jun 3. doi: 10.1097/INF.0000000000005305.
   PubMed     Abstract available
   
   
   
2. CINAR EN, Markowich AH, Vergadi E, Lyall H, et al
   Duration of Postnatal HIV Prophylaxis: How Long Is Long Enough?
   Pediatr Infect Dis J. 2026 Jun 2. doi: 10.1097/INF.0000000000005308.
   PubMed    
   
   
   May 2026
3. LUQUE MT, Du L, Rouzier V, Machado DM, et al
   Use of Integrase Strand Transfer Inhibitors Among Children Living With HIV in Latin America and the Caribbean.
   Pediatr Infect Dis J. 2026 May 22. doi: 10.1097/INF.0000000000005281.
   PubMed     Abstract available
   
   
   
4. RUBIO-DUARTE AF, Garces-Rodriguez MP, Hurtado-Ortiz A, Forero-Manzano MJ, et al
   Severe Pneumocystis jirovecii Pneumonia as the Sentinel Presentation of BENTA Disease: Case Report of a 3-month-old Infant.
   Pediatr Infect Dis J. 2026 May 18. doi: 10.1097/INF.0000000000005288.
   PubMed     Abstract available
   
   
   
5. MARIN M, Raparti L, Leung J, Oliver SE, et al
   Safety and Immunogenicity of Varicella Vaccination in Children and Adolescents Living With HIV: A Systematic Review.
   Pediatr Infect Dis J. 2026 May 11. doi: 10.1097/INF.0000000000005264.
   PubMed     Abstract available
   
   
   April 2026
6. MAHTAB S, Solomon F, Chawana R, Machemedze T, et al
   Causes of Death Among Infants Who Are HIV-exposed and -Unexposed Uninfected Using Minimally Invasive Tissue Sampling in South Africa.
   Pediatr Infect Dis J. 2026;45:348-354.
   PubMed     Abstract available
   
   
   March 2026
7. NANTANEE R, Lolekha R, Lertpiriyasuwat C, Puangtaptim W, et al
   High Viral Suppression Rates and Attrition Rates Among Children With Perinatally Acquired HIV in the Thai National AIDS Program, 2023.
   Pediatr Infect Dis J. 2026;45:251-257.
   PubMed     Abstract available
   
   
   February 2026
8. USAKLIOGLU EROL M, Soguksu P, Kacmaz BB, Mese S, et al
   Uncovering the Hidden Players: Double-negative T Cells in Pediatric HIV and Their Impact on Disease Progression.
   Pediatr Infect Dis J. 2026 Feb 26. doi: 10.1097/INF.0000000000005199.
   PubMed     Abstract available
   
   
   
9. NATUKUNDA E, Szubert AJ, Bwakura-Dangarembizi M, Mulenga V, et al
   Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.
   Pediatr Infect Dis J. 2026 Feb 24. doi: 10.1097/INF.0000000000005195.
   PubMed     Abstract available
   
   
   
10. CHANDASANA H, Buchanan AM, Henegar CA, McKenna M, et al
    Model-informed Dolutegravir Dose Selection in Pediatrics With First-generation INSTI Resistance.
    Pediatr Infect Dis J. 2026 Feb 4. doi: 10.1097/INF.0000000000005158.
    PubMed     Abstract available
    
    
    
11. IZU A, Koen A, Jose L, Cutland C, et al
    Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status.
    Pediatr Infect Dis J. 2026;45:173-180.
    PubMed     Abstract available
    
    
    January 2026
12. GIFFORD A, Mashau R, Mpembe R, Khanyile D, et al
    Cryptococcal Antigenemia in South African Children Living With HIV.
    Pediatr Infect Dis J. 2026 Jan 28. doi: 10.1097/INF.0000000000005154.
    PubMed     Abstract available
    
    
    
13. MASSA JD, Giganti MJ, Lindsey JC, Levin MJ, et al
    Body Mass Index and Vaccine-induced Immune Responses in Children Living With HIV.
    Pediatr Infect Dis J. 2026 Jan 28. doi: 10.1097/INF.0000000000005153.
    PubMed     Abstract available
    
    
    
14. QUAN V, Meiring S, Mashau R, Perovic O, et al
    Maternal-infant Characteristics of Preterm and Term Neonates With Bloodstream Infections in Lower-tier Hospitals in South Africa: A Cross-sectional Study.
    Pediatr Infect Dis J. 2026 Jan 7. doi: 10.1097/INF.0000000000005127.
    PubMed     Abstract available
    
    
    
15. NDJOLO ADA ML, Fokam J, Kamgaing N, Ambe Chenwi C, et al
    Low Rates of Virological Failure and Acquired HIV-1 Drug Resistance Among Children in Cameroon: Evidence Following Transition to Dolutegravir-based Regimens in Pediatrics.
    Pediatr Infect Dis J. 2026 Jan 7. doi: 10.1097/INF.0000000000005118.
    PubMed     Abstract available
    
    
    December 2025
16. HUYNH J, Le NHT, Le Nguyen BH, Hoang HT, et al
    The Utility of a Three-gene Host Response to Discriminate Tuberculous Meningitis From Other Infections in Children.
    Pediatr Infect Dis J. 2025 Dec 23. doi: 10.1097/INF.0000000000005105.
    PubMed     Abstract available
    
    
    
17. TOTAPALLY M, Meyer K, Totapally BR
    The Prevalence and Trend of Nontuberculous Mycobacterial Infection in Hospitalized Children in the United States From 2000 to 2022.
    Pediatr Infect Dis J. 2025 Dec 16. doi: 10.1097/INF.0000000000005099.
    PubMed     Abstract available
    
    
    
18. TORRE P 3RD, Sirag E, Williams PL, Zhang Z, et al
    Hearing Measures in Children Perinatally HIV-exposed and Uninfected in the PHACS SMARTT Study.
    Pediatr Infect Dis J. 2025 Dec 8. doi: 10.1097/INF.0000000000005098.
    PubMed     Abstract available
    
    
    November 2025
19. AGATHIS NT, Sato K, O'Connor S, Robaugh RIB, et al
    Linking Children and Adolescents With TB Disease to HIV Services in 16 PEPFAR-supported High TB/HIV-Burden Countries in Sub-Saharan Africa, October 2018-September 2022.
    Pediatr Infect Dis J. 2025 Nov 25. doi: 10.1097/INF.0000000000005048.
    PubMed     Abstract available
    
    
    October 2025
20. CAGLAR I, Bag O, Yilmaz Celebi M, Kiymet E, et al
    Evaluation of Adherence to HIV Postexposure Prophylaxis and Follow-up in Pediatric Sexual Assault Victims in Turkey: A Tertiary Center Experience.
    Pediatr Infect Dis J. 2025 Oct 8. doi: 10.1097/INF.0000000000004984.
    PubMed     Abstract available
    
    
    September 2025
21. MORAA H, Njuguna IN, Mburu C, John-Stewart G, et al
    Missed Opportunities to Prevent Mortality Among Youth Living With HIV: Insights From Verbal Autopsies and Clinical Record Reviews.
    Pediatr Infect Dis J. 2025 Sep 26. doi: 10.1097/INF.0000000000005005.
    PubMed     Abstract available
    
    
    
22. TANUMA J, Jiamsakul A, Ross J, Lee MP, et al
    Pregnancy Outcomes After HIV Diagnosis in Women Living With HIV in Japan, South Korea and Hong Kong Special Administrative Region: A Brief Report.
    Pediatr Infect Dis J. 2025 Sep 10. doi: 10.1097/INF.0000000000004989.
    PubMed     Abstract available
    
    
    August 2025
23. LOMBAARD J, Ssali F, Moolasart V, Guarino A, et al
    Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Switching to Oral Rilpivirine in Combination With Other Antiretroviral Therapy in Virologically Suppressed Children Living With HIV-1 Infection: Forty-eight-week Results From the Phase 2
    Pediatr Infect Dis J. 2025 Aug 13. doi: 10.1097/INF.0000000000004943.
    PubMed     Abstract available
    
    
    
24. BURKHARDT I, Ruswa N, Iitana M, Ekandjo H, et al
    Epidemiology and Outcomes of Pediatric Multidrug-resistant Tuberculosis in Namibia: A Retrospective Review of National Registry Data From 2013 to 2023.
    Pediatr Infect Dis J. 2025 Aug 6. doi: 10.1097/INF.0000000000004933.
    PubMed     Abstract available
    
    
    July 2025
25. KABAMI J, Kabageni S, Koss CA, Okiring J, et al
    A Peer-Mother Counseling Intervention Improves Early Infant HIV Testing in Rural Uganda.
    Pediatr Infect Dis J. 2025 Jul 22:10.1097/INF.0000000000004884.
    PubMed     Abstract available
    
    
    
26. HAGENS L, Bevers LAH, Malaba TR, Nassiwa SC, et al
    The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2).
    Pediatr Infect Dis J. 2025 Jul 18. doi: 10.1097/INF.0000000000004902.
    PubMed     Abstract available
    
    
    June 2025
27. GHAMBI-ZULU L, Nyirenda J, Chawinga C, Mtolongo R, et al
    Respiratory Microbial Codetection and Clinical Profiles of Infants Living With HIV Hospitalized With Severe Pneumonia in Malawi.
    Pediatr Infect Dis J. 2025 Jun 20. doi: 10.1097/INF.0000000000004907.
    PubMed     Abstract available
    
    
    
28. DOWLING S, Hackett S, Simao L, Hast M, et al
    Accelerating Uptake of Optimal Antiretrovirals for Children and Adolescents Living With HIV in Nigeria, Tanzania, Uganda and Zambia Through Data-driven Quality Improvement Interventions.
    Pediatr Infect Dis J. 2025 Jun 6. doi: 10.1097/INF.0000000000004893.
    PubMed     Abstract available
    
    
    May 2025
29. RABIE H, Yin DE, Ward S, Rani Y, et al
    Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results.
    Pediatr Infect Dis J. 2025 May 23. doi: 10.1097/INF.0000000000004859.
    PubMed     Abstract available
    
    
    
30. WACHARACHAISURAPOL N, Rungsapphaiboon A, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2025;44:428-430.
    PubMed     Abstract available
    
    
    April 2025
31. LOMBAARD J, Moolasart V, Lutaakome J, Van Solingen-Ristea R, et al
    Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naive Children With HIV >/=6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study.
    Pediatr Infect Dis J. 2025 Apr 18. doi: 10.1097/INF.0000000000004828.
    PubMed     Abstract available
    
    
    
32. PRABHUDAS-STRYCKER K, Waugh M, Bates B, Weaver B, et al
    Postpandemic Trends and Missed Opportunities in Prevention and Diagnosis of Pediatric HIV.
    Pediatr Infect Dis J. 2025 Apr 15. doi: 10.1097/INF.0000000000004822.
    PubMed     Abstract available
    
    
    
33. ANTWI S, Enimil A, Yang H, Martyn-Dickens C, et al
    Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection.
    Pediatr Infect Dis J. 2025 Apr 10. doi: 10.1097/INF.0000000000004831.
    PubMed     Abstract available
    
    
    
34. PATTEN G, Malateste K, Bolton Moore C, Sipambo N, et al
    Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV.
    Pediatr Infect Dis J. 2025 Apr 4. doi: 10.1097/INF.0000000000004819.
    PubMed     Abstract available
    
    
    
35. FOUGERE Y, Brophy J, Hawkes MT, Lee T, et al
    Clinical and Immunologic Impact of CMV Coinfection Among Children Living With HIV in Canada.
    Pediatr Infect Dis J. 2025 Apr 3. doi: 10.1097/INF.0000000000004811.
    PubMed     Abstract available
    
    
    
36. JACOBS TG, Ooms GI, Mantel-Teeuwisse AK, Suleman F, et al
    Commentary: Pediatric HIV Treatment: Nurturing Access Through Health Facility Availability and Stock-out Monitoring.
    Pediatr Infect Dis J. 2025 Apr 3. doi: 10.1097/INF.0000000000004814.
    PubMed    
    
    
    March 2025
37. TORRE P 3RD, Elliott H, Shinn J, Mangino AA, et al
    Central Auditory Processing in Children is Affected by Perinatal HIV Exposure.
    Pediatr Infect Dis J. 2025 Mar 12. doi: 10.1097/INF.0000000000004796.
    PubMed     Abstract available
    
    
    February 2025
38. GILL MM, Khumalo PN, Hoffman HJ, Chouraya C, et al
    Birth Defects and Adverse Pregnancy Outcomes in Hospital-based Birth Surveillance in Eswatini.
    Pediatr Infect Dis J. 2025 Feb 3. doi: 10.1097/INF.0000000000004745.
    PubMed     Abstract available
    
    
    
39. BOURNE J, Sawry S, Le Roux J, Fairlie L, et al
    Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
40. DANIEL O, Nalwoga J, Kyohere M, Nsimire Sendagala J, et al
    Impact of HIV Status on Group B Streptococcus Colonization and Antibody Responses in Serum and Vaginal Mucosa.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    January 2025
41. PEREIRA MO, Ribeiro M, Patraquim C, Alves MC, et al
    Advanced HIV Disease in Children: Clinical Practice Cases in Portugal.
    Pediatr Infect Dis J. 2025 Jan 30. doi: 10.1097/INF.0000000000004750.
    PubMed    
    
    
    
42. ODERO L, Chafetz A, Gikura M, Goldstein D, et al
    The Impact of Aging on Measurement of Continuity of Treatment Among Children Living With HIV in the PEPFAR Supported Program in Kenya.
    Pediatr Infect Dis J. 2025 Jan 30. doi: 10.1097/INF.0000000000004702.
    PubMed     Abstract available
    
    
    
43. WILLIAMS T, Unternaher J, Koay WLA, Anderson L, et al
    Efficacy, Safety and Retention in Care Among Adolescents and Youth With HIV on Long-Acting Injectable Cabotegravir/Rilpivirine Treatment: Real-World Observational Cohort Outcomes.
    Pediatr Infect Dis J. 2025 Jan 24. doi: 10.1097/INF.0000000000004742.
    PubMed     Abstract available
    
    
    
44. MAGDALENO AM, Friedrich L, Ramos MA, Corso AL, et al
    Prevalence of Anti-HIV Antibodies at 12 Months of Age in Infants Exposed to HIV.
    Pediatr Infect Dis J. 2025 Jan 17. doi: 10.1097/INF.0000000000004732.
    PubMed     Abstract available
    
    
    
45. WACHARACHAISURAPOL N, Rungsapphaiboon A, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2025 Jan 10. doi: 10.1097/INF.0000000000004683.
    PubMed     Abstract available
    
    
    
46. SUNDAR KG, Yang LZ, Cambou MC, Varella IRS, et al
    Prompt Initiation of Maternal Antiretroviral Therapy After HIV Seroconversion in Pregnancy Effectively Prevents Vertical Transmission and Other Adverse Infant Outcomes.
    Pediatr Infect Dis J. 2025;44:40-43.
    PubMed     Abstract available
    
    
    December 2024
47. ALONSO YANEZ S, Juarez Lorenzana JW, Prieto Tato L, Guillen Martin S, et al
    Impact of the COVID-19 Pandemic on the Follow-up of Children and Adolescents With HIV Infection in Guatemala.
    Pediatr Infect Dis J. 2024 Dec 23. doi: 10.1097/INF.0000000000004674.
    PubMed     Abstract available
    
    
    
48. BARDAJI A, Dobano C, Alonso S, Vala A, et al
    Effect of HIV and Malaria in Pregnancy on Pertussis-specific Antibodies and Transplacental Antibody Transfer: A Secondary Analysis of a Prospective Cohort Study in Mozambican Pregnant Women and Their Infants.
    Pediatr Infect Dis J. 2024 Dec 4. doi: 10.1097/INF.0000000000004647.
    PubMed     Abstract available
    
    
    November 2024
49. MUNOZ FM, Beigi R, Posavad CM, Kelly C, et al
    Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
    Pediatr Infect Dis J. 2024;43:1065-1073.
    PubMed     Abstract available
    
    
    October 2024
50. DUBOIS MM, Jao J, Sun S, Legbedze J, et al
    Infectious Morbidity and All-cause Mortality of Infants HIV-exposed Uninfected Compared to Infants HIV-unexposed Uninfected in Botswana.
    Pediatr Infect Dis J. 2024 Oct 31. doi: 10.1097/INF.0000000000004603.
    PubMed     Abstract available
    
    
    
51. MRUBATA KL, Bailie V, Solomon F, Izu A, et al
    Impact of Respiratory Syncytial Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection on Clinical Severity and Outcomes Among Children Hospitalized With Lower Respiratory Tract Infections in Soweto, South Africa.
    Pediatr Infect Dis J. 2024 Oct 2. doi: 10.1097/INF.0000000000004560.
    PubMed     Abstract available
    
    
    August 2024
52. CHAPMAN KS, Luhanga M, Mtonga G, Agathis N, et al
    Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022.
    Pediatr Infect Dis J. 2024 Aug 5. doi: 10.1097/INF.0000000000004491.
    PubMed     Abstract available
    
    
    
53. RUNGSAPPHAIBOON A, Wacharachaisurapol N, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2024;43:789-794.
    PubMed     Abstract available
    
    
    July 2024
54. DE BEER ST, Davies MA, Phelanyane F, Jones HE, et al
    The Retrospective Implementation of Standardized In Utero HIV Exposure Definitions Using Routinely Collected Public Sector Data Across the Western Cape Province, South Africa.
    Pediatr Infect Dis J. 2024 Jul 24. doi: 10.1097/INF.0000000000004486.
    PubMed     Abstract available
    
    
    
55. ANDERSON K, van Zyl G, Hsiao NY, Claassen M, et al
    HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South Africa.
    Pediatr Infect Dis J. 2024 Jul 23. doi: 10.1097/INF.0000000000004482.
    PubMed     Abstract available
    
    
    
56. KAKANDE E, Ssekyanzi B, Abbott R, Ariho W, et al
    Prevalence and Predictors of Tuberculosis Infection in Children and Adolescents in Rural Uganda: A Cross-sectional Study.
    Pediatr Infect Dis J. 2024 Jul 15. doi: 10.1097/INF.0000000000004475.
    PubMed     Abstract available
    
    
    
57. MADHI SA, Ceballos A, Cousin L, Domachowske JB, et al
    Population Attributable Risk of Wheeze in 2-<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life.
    Pediatr Infect Dis J. 2024 Jul 1. doi: 10.1097/INF.0000000000004447.
    PubMed     Abstract available
    
    
    June 2024
58. HOMANS J, Blieden C
    Maternal Syphilis Leading to High Efficiency In Utero Transmission of Antiretroviral Resistant HIV: Intersection of Two Pandemics.
    Pediatr Infect Dis J. 2024 Jun 12. doi: 10.1097/INF.0000000000004414.
    PubMed     Abstract available
    
    
    May 2024
59. RUNGSAPPHAIBOON A, Wacharachaisurapol N, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2024 May 20. doi: 10.1097/INF.0000000000004366.
    PubMed     Abstract available
    
    
    
60. COMBS M, Johnson A, Abbotsford J, Bowen AC, et al
    Evaluation of Pediatric HIV Postexposure Prophylaxis Guideline Following Child Sexual Assault in Western Australia.
    Pediatr Infect Dis J. 2024 May 7. doi: 10.1097/INF.0000000000004370.
    PubMed     Abstract available
    
    
    March 2024
61. GREYBE L, Barnabas S, Cotton M, Rose P, et al
    Cardiometabolic Risk Profiles of Adolescents Living With Perinatally Acquired HIV in South Africa.
    Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004340.
    PubMed     Abstract available
    
    
    February 2024
62. NYAKATO P, Boulle A, Wood R, Eley B, et al
    Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial Records.
    Pediatr Infect Dis J. 2024 Feb 21. doi: 10.1097/INF.0000000000004281.
    PubMed     Abstract available
    
    
    
63. KENNEALLY AM, Bates BN
    Accidental Raltegravir Overdose in a Neonate: Case Report and Review of Literature.
    Pediatr Infect Dis J. 2024 Feb 6. doi: 10.1097/INF.0000000000004273.
    PubMed    
    
    
    
64. MALIK F, Crichton S, Plotnikova Y, Latysheva I, et al
    Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe.
    Pediatr Infect Dis J. 2024 Feb 2. doi: 10.1097/INF.0000000000004271.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum